PF4 and psoriasis: Tamagawa-Mineoka et al. reported increased plasma levels of β-thromboglobulin and platelet factor 4 (another platelet chemokine) in patients with psoriasis which were both correlated with PASI and significantly reduced following successful treatment, suggesting a pathomechanistic contribution to disease activity [72].